{
    "clinical_study": {
        "@rank": "122597", 
        "arm_group": [
            {
                "arm_group_label": "Palmer arsenical keratosis", 
                "arm_group_type": "Experimental", 
                "description": "Spirulina 10 g/day orally for 12 weeks"
            }, 
            {
                "arm_group_label": "Arsenic exposed controls", 
                "arm_group_type": "Active Comparator", 
                "description": "Spirulina 10 g/day orally for 12 weeks"
            }, 
            {
                "arm_group_label": "Heathy volunteers", 
                "arm_group_type": "Active Comparator", 
                "description": "Spirulina 10 g/day orally for 12 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "Patients of arsenical keratosis may be treated with spirulina. Is this improvement related\n      to the levels of zinc, vitamin E and linoleic acid at the site of the keratosis (palm)? To\n      understand this, patients of palmer arsenical keratosis (n=10), arsenic exposed controls\n      (n=10) and healthy volunteers (n=10) will be treated with spirulina powder 10 g/day orally\n      for 12 weeks. Skin extracts will be collected both before and after supplementation from the\n      palm and dorsum for estimation of zinc, vitamin E and linoleic acid levels."
        }, 
        "brief_title": "Effect of Spirulina on Zinc, Vitamin E and Linoleic Acid Levels in Palm Skin Following Chronic Exposure to Arsenic", 
        "completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "condition": "Arsenical Keratosis", 
        "condition_browse": {
            "mesh_term": [
                "Keratosis", 
                "Keratosis, Actinic"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients of arsenical keratosis remain untreated due to unavailability of effective drug. To\n      find out an effective drug, the pathogenesis of keratosis should be understood. Spirulina is\n      one of the dietary supplements, that improves the symptoms of keratosis. Is this improvement\n      related to the levels of zinc, vitamin E and linoleic acid at the site of the keratosis\n      (palm)? Ten patients of moderate palmer arsenical keratosis will be treated with spirulina\n      powder 10 g/day orally for 12 weeks. Skin extracts will be collected both before and after\n      supplementation from the palm and dorsum using a mixture of chloroform and ethanol. Zinc,\n      vitamin E and linoleic acid levels will be estimated from the extracts. Similar protocol of\n      spirulina administration and the collection of skin extracts will be done in arsenic exposed\n      controls (n=10) and healthy volunteers (n=10)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria (Patients):\n\n          -  moderate palmer keratosis\n\n          -  drink arsenic contaminated water (>50 \u00b5g/L) for at least 6 months\n\n          -  voluntarily agree to participate\n\n        Inclusion Criteria (Arsenic exposed controls):\n\n          -  no symptoms of keratosis\n\n          -  family member of the patient\n\n          -  drink arsenic contaminated water (>50 \u00b5g/L) for at least 6 months\n\n          -  voluntarily agree to participate\n\n        Inclusion Criteria (Healthy volunteers):\n\n          -  no symptoms of keratosis\n\n          -  drink arsenic safe water (<50 \u00b5g/L)\n\n          -  voluntarily agree to participate\n\n        Exclusion Criteria:\n\n          -  pregnancy\n\n          -  lactation\n\n          -  chronic diseases: diabetes mellitus, rheumatoid arthritis, tuberculosis\n\n          -  arsenicosis patients under treatment in the previous 3 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01752972", 
            "org_study_id": "BSMMU-006-CT"
        }, 
        "intervention": {
            "arm_group_label": [
                "Palmer arsenical keratosis", 
                "Arsenic exposed controls", 
                "Heathy volunteers"
            ], 
            "description": "10 g/day orally for 12 weeks", 
            "intervention_name": "Spirulina", 
            "intervention_type": "Dietary Supplement"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin E", 
                "Alpha-Tocopherol", 
                "Tocopherols", 
                "Tocotrienols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Arsenic", 
            "Keratosis", 
            "Linoleic acid", 
            "Palm", 
            "Spirulina", 
            "Vitamin E", 
            "Zinc"
        ], 
        "lastchanged_date": "December 17, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Dhaka", 
                    "country": "Bangladesh"
                }, 
                "name": "Bangabandhu Sheikh Mujib Medical University"
            }
        }, 
        "location_countries": {
            "country": "Bangladesh"
        }, 
        "number_of_arms": "3", 
        "official_title": "Effect of Spirulina on the Levels of Zinc, Vitamin E and Linoleic Acid in the Palm Skin Extracts of People With Prolonged Exposure to Arsenic", 
        "overall_official": {
            "affiliation": "Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh", 
            "last_name": "Mir Misbahuddin, MBBS, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Bangladesh: Ethical Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change in vitamin E levels in skin palm extract following supplementation with spirulina", 
            "safety_issue": "No", 
            "time_frame": "0 week (baseline), 12 weeks (end)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01752972"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh", 
            "investigator_full_name": "Prof. Mir Misbahuddin", 
            "investigator_title": "Prof. and Chairman", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in zinc levels in skin palm extract following supplementation with spirulina", 
                "safety_issue": "No", 
                "time_frame": "0 week (baseline), 12 weeks (end)"
            }, 
            {
                "measure": "Change in linoleic acid levels in skin palm extract following supplementation with spirulina", 
                "safety_issue": "No", 
                "time_frame": "0 week (baseline), 12 weeks (end)"
            }
        ], 
        "source": "Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2011", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}